Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in AdultsDick Menzies, Andrea Benedetti, Mênonli Adjobimey et al.|New England Journal of Medicine|2018Cited by 392
The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis StudyJ. Brent Richards, David Goltzman, Lawrence Joseph et al.|Osteoporosis International|2006Cited by 68
Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different SettingsMayara Lisboa Bastos, Dick Menzies, Jonathon R. Campbell et al.|Annals of Internal Medicine|2020Cited by 31
Safety and Efficacy of Rifampin or Isoniazid Among People With <i>Mycobacterium tuberculosis</i> Infection and Living With Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized TrialsJonathon R. Campbell, Dick Menzies, Hamdan Al‐Jahdali et al.|Clinical Infectious Diseases|2020Cited by 27
Predicting Risk of Tuberculosis (TB) Disease in People Who Migrate to a Low-TB Incidence Country: Development and Validation of a Multivariable, Dynamic Risk-Prediction Model Using Health Administrative DataJoseph H. Puyat, James C. Johnston, Elizabeth Rea et al.|Clinical Infectious Diseases|2024Cited by 8